IM Cannabis Corp. explores U.S. expansion, divestitures with new financial advisors.

IMC, a medical cannabis company with operations in Israel and Germany, is exploring US cannabis market entry opportunities. Following President Trump's executive order, IMC is evaluating strategic US expansion and potential divestitures of its German and Israeli operations. The company has engaged SSC Advisors as financial advisors to assist with the process.